Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

A Patient with Neuroferritinopathy Presenting with Juvenile-Onset Voice Tremor.

Park CW, Kim NY, Kim YJ, Song SK, Lyoo CH.

J Mov Disord. 2019 Aug 9. doi: 10.14802/jmd.19038. [Epub ahead of print] No abstract available.

2.

"Depressed" caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson's disease.

Yoo SW, Oh YS, Hwang EJ, Ryu DW, Lee KS, Lyoo CH, Kim JS.

Neurobiol Dis. 2019 Aug 1;132:104563. doi: 10.1016/j.nbd.2019.104563. [Epub ahead of print]

PMID:
31377233
3.

Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease.

Lee MJ, Pak K, Kim JH, Kim YJ, Yoon J, Lee J, Lyoo CH, Park HJ, Lee JH, Jung NY.

Neurology. 2019 Aug 13;93(7):e665-e674. doi: 10.1212/WNL.0000000000007939. Epub 2019 Jul 9.

PMID:
31289143
4.

Progressive tau accumulation in Alzheimer's disease: two-year follow-up study.

Cho H, Choi JY, Lee HS, Lee JH, Ryu YH, Lee MS, Jack CR Jr, Lyoo CH.

J Nucl Med. 2019 Mar 29. pii: jnumed.118.221697. doi: 10.2967/jnumed.118.221697. [Epub ahead of print]

PMID:
30926651
5.

Striatal dopamine activity and myocardial 123I-metaiodobenzylguanidine uptake in early Parkinson's disease.

Oh YS, Kim JS, Yoo SW, Hwang EJ, Lyoo CH, Lee KS.

Parkinsonism Relat Disord. 2019 Jun;63:156-161. doi: 10.1016/j.parkreldis.2019.02.012. Epub 2019 Feb 14.

PMID:
30796009
6.

Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease.

Franzmeier N, Rubinski A, Neitzel J, Kim Y, Damm A, Na DL, Kim HJ, Lyoo CH, Cho H, Finsterwalder S, Duering M, Seo SW, Ewers M; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2019 Apr 1;142(4):1093-1107. doi: 10.1093/brain/awz026.

PMID:
30770704
7.

Novel Ferritin Light Chain Gene Mutation in a Korean Patient with Neuroferritinopathy.

Yoon SH, Kim NY, Kim YJ, Lyoo CH.

J Mov Disord. 2019 Jan;12(1):63-65. doi: 10.14802/jmd.18062. Epub 2019 Jan 30. No abstract available.

8.

Automatic Extraction of a Reference Region for the Noninvasive Quantification of Translocator Protein in Brain Using 11C-PBR28.

Zanotti-Fregonara P, Kreisl WC, Innis RB, Lyoo CH.

J Nucl Med. 2019 Jul;60(7):978-984. doi: 10.2967/jnumed.118.222927. Epub 2019 Jan 17.

PMID:
30655330
9.

18F-flortaucipir uptake patterns in clinical subtypes of primary progressive aphasia.

Cho H, Kim HJ, Choi JY, Ryu YH, Lee MS, Na DL, Seo SW, Lyoo CH.

Neurobiol Aging. 2019 Mar;75:187-197. doi: 10.1016/j.neurobiolaging.2018.11.017. Epub 2018 Nov 23.

PMID:
30594046
10.

Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.

Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Schöll M, Strandberg O, Palmqvist S, Mattsson N, Janelidze S, Santillo A, Ohlsson T, Jögi J, Tsai R, La Joie R, Kramer J, Boxer AL, Gorno-Tempini ML, Miller BL, Choi JY, Ryu YH, Lyoo CH, Hansson O.

JAMA. 2018 Sep 18;320(11):1151-1162. doi: 10.1001/jama.2018.12917.

11.

Decreased Cannabinoid CB1 Receptors in Male Tobacco Smokers Examined With Positron Emission Tomography.

Hirvonen J, Zanotti-Fregonara P, Gorelick DA, Lyoo CH, Rallis-Frutos D, Morse C, Zoghbi SS, Pike VW, Volkow ND, Huestis MA, Innis RB.

Biol Psychiatry. 2018 Nov 15;84(10):715-721. doi: 10.1016/j.biopsych.2018.07.009. Epub 2018 Jul 21.

12.

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects.

Richards EM, Zanotti-Fregonara P, Fujita M, Newman L, Farmer C, Ballard ED, Machado-Vieira R, Yuan P, Niciu MJ, Lyoo CH, Henter ID, Salvadore G, Drevets WC, Kolb H, Innis RB, Zarate CA Jr.

EJNMMI Res. 2018 Jul 3;8(1):57. doi: 10.1186/s13550-018-0401-9.

13.

Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.

Lee SH, Lee MJ, Lyoo CH, Cho H, Lee MS.

J Neural Transm (Vienna). 2018 Sep;125(9):1333-1339. doi: 10.1007/s00702-018-1901-5. Epub 2018 Jul 3.

PMID:
29971496
14.

Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease.

Oh YS, Kim JS, Hwang EJ, Lyoo CH.

Parkinsonism Relat Disord. 2018 Nov;56:47-51. doi: 10.1016/j.parkreldis.2018.06.022. Epub 2018 Jun 14.

PMID:
29925486
15.

Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.

Kim HJ, Park S, Cho H, Jang YK, San Lee J, Jang H, Kim Y, Kim KW, Ryu YH, Choi JY, Moon SH, Weiner MW, Jagust WJ, Rabinovici GD, DeCarli C, Lyoo CH, Na DL, Seo SW.

JAMA Neurol. 2018 Aug 1;75(8):999-1007. doi: 10.1001/jamaneurol.2018.0975.

16.

Predicted sequence of cortical tau and amyloid-β deposition in Alzheimer disease spectrum.

Cho H, Lee HS, Choi JY, Lee JH, Ryu YH, Lee MS, Lyoo CH.

Neurobiol Aging. 2018 Aug;68:76-84. doi: 10.1016/j.neurobiolaging.2018.04.007. Epub 2018 Apr 17.

PMID:
29751288
17.

Increased Uptake of AV-1451 in a Subacute Infarction Lesion.

Cho SH, Cho H, Park S, Ryu YH, Choi JY, Lyoo CH, Na DL, Seo SW, Kim HJ.

Yonsei Med J. 2018 Jun;59(4):563-565. doi: 10.3349/ymj.2018.59.4.563.

18.

Predominant subcortical accumulation of 18F-flortaucipir binding in behavioral variant frontotemporal dementia.

Cho H, Seo SW, Choi JY, Lee HS, Ryu YH, Lee MS, Na DL, Kim HJ, Lyoo CH.

Neurobiol Aging. 2018 Jun;66:112-121. doi: 10.1016/j.neurobiolaging.2018.02.015. Epub 2018 Feb 21.

PMID:
29554554
19.

Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson's disease.

Pak K, Shin HK, Kim EJ, Lee JH, Lyoo CH, Son J, Lee MJ.

Parkinsonism Relat Disord. 2018 Jun;51:67-72. doi: 10.1016/j.parkreldis.2018.02.044. Epub 2018 Feb 28.

PMID:
29510907
20.

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.

Lyoo CH, Cho H, Choi JY, Ryu YH, Lee MS.

J Mov Disord. 2018 Jan;11(1):1-12. doi: 10.14802/jmd.17071. Epub 2018 Jan 23. Review.

21.

Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.

Lee SH, Cho H, Choi JY, Lee JH, Ryu YH, Lee MS, Lyoo CH.

Mov Disord. 2018 Feb;33(2):262-272. doi: 10.1002/mds.27252. Epub 2017 Nov 23.

PMID:
29168583
22.

Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia.

Jang YK, Lyoo CH, Park S, Oh SJ, Cho H, Oh M, Ryu YH, Choi JY, Rabinovici GD, Kim HJ, Moon SH, Jang H, Lee JS, Jagust WJ, Na DL, Kim JS, Seo SW.

Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):432-442. doi: 10.1007/s00259-017-3876-0. Epub 2017 Nov 16.

PMID:
29143870
23.

Brain regional iron contents in progressive supranuclear palsy.

Lee SH, Lyoo CH, Ahn SJ, Rinne JO, Lee MS.

Parkinsonism Relat Disord. 2017 Dec;45:28-32. doi: 10.1016/j.parkreldis.2017.09.020. Epub 2017 Sep 28.

PMID:
28982612
24.

18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome.

Cho H, Baek MS, Choi JY, Lee SH, Kim JS, Ryu YH, Lee MS, Lyoo CH.

Neurology. 2017 Sep 12;89(11):1170-1178. doi: 10.1212/WNL.0000000000004364. Epub 2017 Aug 16.

PMID:
28814462
25.

Off-Target 18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation.

Choi JY, Cho H, Ahn SJ, Lee JH, Ryu YH, Lee MS, Lyoo CH.

J Nucl Med. 2018 Jan;59(1):117-120. doi: 10.2967/jnumed.117.195248. Epub 2017 Aug 3.

26.

Parkinsonian Patients with Striatal Cribriform State Present Rapidly Progressive Axial Parkinsonism.

Lee SH, Lyoo CH, Cho H, Rinne JO, Lee MS.

Eur Neurol. 2017;78(3-4):119-124. doi: 10.1159/000479227. Epub 2017 Jul 26.

PMID:
28746923
27.

A Patient with Recurrent Dyskinesia and Hyperpyrexia Syndrome.

Baek MS, Lee HW, Lyoo CH.

J Mov Disord. 2017 Sep;10(3):154-157. doi: 10.14802/jmd.17022. Epub 2017 Jul 14.

28.

Paroxysmal freezing of gait in a patient with mesial frontal transient ischemic attacks.

Hwang HW, Lee SH, Lyoo CH, Lee MS.

BMC Neurol. 2017 Jun 28;17(1):122. doi: 10.1186/s12883-017-0901-7.

29.

18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.

Kim HJ, Cho H, Werring DJ, Jang YK, Kim YJ, Lee JS, Lee J, Jun S, Park S, Ryu YH, Choi JY, Cho YS, Moon SH, Na DL, Lyoo CH, Seo SW.

J Alzheimers Dis. 2017;57(3):711-716. doi: 10.3233/JAD-161139.

PMID:
28282808
30.

Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.

Cho H, Choi JY, Lee SH, Lee JH, Choi YC, Ryu YH, Lee MS, Lyoo CH.

Neurobiol Aging. 2017 May;53:103-111. doi: 10.1016/j.neurobiolaging.2017.01.024. Epub 2017 Feb 9.

PMID:
28254589
31.

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism.

Lee SH, Kim HK, Lee YG, Lyoo CH, Ahn SJ, Lee MS.

J Mov Disord. 2017 Jan;10(1):35-39. doi: 10.14802/jmd.16045. Epub 2016 Dec 27.

32.

Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease.

Kreisl WC, Lyoo CH, Liow JS, Snow J, Page E, Jenko KJ, Morse CL, Zoghbi SS, Pike VW, Turner RS, Innis RB.

Neurobiol Aging. 2017 Mar;51:132-140. doi: 10.1016/j.neurobiolaging.2016.12.006. Epub 2016 Dec 16.

33.

Impact of Prolonged Temporal Discrimination Threshold on Finger Movements of Parkinson's Disease.

Lee MJ, Son JS, Lee JH, Kim SJ, Lyoo CH, Lee MS.

PLoS One. 2016 Nov 28;11(11):e0167034. doi: 10.1371/journal.pone.0167034. eCollection 2016.

34.

A prognostic factor in focal hand dystonia: typist's cramp cases and literature review.

Ham JH, Kim SJ, Song SK, Lyoo CH, Lee PH, Sohn YH, Kang SY.

J Neurol Sci. 2016 Dec 15;371:85-87. doi: 10.1016/j.jns.2016.10.028. Epub 2016 Oct 19. Review.

PMID:
27871456
35.

18 F-AV-1451 binds to putamen in multiple system atrophy.

Cho H, Choi JY, Lee SH, Ryu YH, Lee MS, Lyoo CH.

Mov Disord. 2017 Jan;32(1):171-173. doi: 10.1002/mds.26857. Epub 2016 Nov 9. No abstract available.

PMID:
27859717
36.

Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease.

Hong JH, Kim YK, Park JS, Lee JE, Oh MS, Chung EJ, Kim JY, Sung YH, Lyoo CH, Lee JH, Kwon DY, Kim HS, Shin HW, Park SA, Park IS, Kim JS, Lee PH, Koh SB, Baik JS, Kim SJ, Ma HI, Kim JW, Kim YJ.

J Clin Neurosci. 2017 Feb;36:108-113. doi: 10.1016/j.jocn.2016.10.013. Epub 2016 Nov 10.

PMID:
27839916
37.

Subcortical 18 F-AV-1451 binding patterns in progressive supranuclear palsy.

Cho H, Choi JY, Hwang MS, Lee SH, Ryu YH, Lee MS, Lyoo CH.

Mov Disord. 2017 Jan;32(1):134-140. doi: 10.1002/mds.26844. Epub 2016 Nov 3.

PMID:
27813160
38.

Biodistribution and Radiation Dosimetry of [18F]Mefway in Humans.

Choi JY, Lyoo CH, Kim JS, Kim KM, Lee M, Ryu YH.

Mol Imaging Biol. 2016 Dec;18(6):803-806.

PMID:
27126460
39.

Delayed iron deposit and atrophy of the putamen in a case with osmotic demyelination syndrome.

Lee MS, Lee SH, Kim HK, Ahn SJ, Lyoo CH.

J Neurol Sci. 2016 Oct 15;369:131-133. doi: 10.1016/j.jns.2016.08.018. Epub 2016 Aug 9. No abstract available.

PMID:
27653878
40.

Comparison of two PET radioligands, [11C]FPEB and [11C]SP203, for quantification of metabotropic glutamate receptor 5 in human brain.

Lohith TG, Tsujikawa T, Siméon FG, Veronese M, Zoghbi SS, Lyoo CH, Kimura Y, Morse CL, Pike VW, Fujita M, Innis RB.

J Cereb Blood Flow Metab. 2017 Jul;37(7):2458-2470. doi: 10.1177/0271678X16668891. Epub 2016 Jan 1.

41.

Tau PET in Alzheimer disease and mild cognitive impairment.

Cho H, Choi JY, Hwang MS, Lee JH, Kim YJ, Lee HM, Lyoo CH, Ryu YH, Lee MS.

Neurology. 2016 Jul 26;87(4):375-83. doi: 10.1212/WNL.0000000000002892. Epub 2016 Jun 29.

PMID:
27358341
42.

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.

Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, Lee JH, Ryu YH, Lee MS, Lyoo CH.

Ann Neurol. 2016 Aug;80(2):247-58. doi: 10.1002/ana.24711. Epub 2016 Jul 8.

PMID:
27323247
43.

(11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease.

Kreisl WC, Lyoo CH, Liow JS, Wei M, Snow J, Page E, Jenko KJ, Morse CL, Zoghbi SS, Pike VW, Turner RS, Innis RB.

Neurobiol Aging. 2016 Aug;44:53-61. doi: 10.1016/j.neurobiolaging.2016.04.011. Epub 2016 Apr 27.

44.

A Dextral Primary Progressive Aphasia Patient with Right Dominant Hypometabolism and Tau Accumulation and Left Dominant Amyloid Accumulation.

Jang YK, Park S, Kim HJ, Cho H, Lyoo CH, Seo SW, Na DL.

Case Rep Neurol. 2016 Apr 19;8(1):78-86. doi: 10.1159/000445538. eCollection 2016 Jan-Apr.

45.

Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.

Lyoo CH, Cho H, Choi JY, Hwang MS, Hong SK, Kim YJ, Ryu YH, Lee MS.

J Alzheimers Dis. 2016;51(3):671-5. doi: 10.3233/JAD-151052.

PMID:
26890779
46.

Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans.

Lee JH, Park J, Ryu HS, Park H, Kim YE, Hong JY, Nam SO, Sung YH, Lee SH, Lee JY, Lee MJ, Kim TH, Lyoo CH, Chung SJ, Koh SB, Lee PH, Cho JW, Park MY, Kim YJ, Sohn YH, Jeon BS, Lee MS.

J Mov Disord. 2016 Jan;9(1):20-7. doi: 10.14802/jmd.15058. Epub 2016 Jan 25.

47.

Human Radiation Dosimetry of [(18)F]AV-1451(T807) to Detect Tau Pathology.

Choi JY, Lyoo CH, Lee JH, Cho H, Kim KM, Kim JS, Ryu YH.

Mol Imaging Biol. 2016 Aug;18(4):479-82. doi: 10.1007/s11307-015-0924-7.

PMID:
26728162
48.

Optimal timing of [¹⁸F]Mefway PET for imaging the serotonin 1A receptor in healthy male subjects.

Lee JH, Ryu YH, Lyoo CH, Choi SH, Kim JJ, Choi JY.

Appl Radiat Isot. 2016 Jan;107:127-132. doi: 10.1016/j.apradiso.2015.10.004. Epub 2015 Oct 9.

PMID:
26492323
49.

P-Glycoprotein, not BCRP, Limits the Brain Uptake of [(18)F]Mefway in Rodent Brain.

Choi JY, Song JS, Lee M, Cho WK, Chung J, Lyoo CH, Kim CH, Park J, Lee KC, Kim KM, Kang JH, Bae MA, Ryu YH.

Mol Imaging Biol. 2016 Apr;18(2):267-73. doi: 10.1007/s11307-015-0883-z.

PMID:
26250653
50.

Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.

Kim JS, Cho H, Choi JY, Lee SH, Ryu YH, Lyoo CH, Lee MS.

PLoS One. 2015 Jul 6;10(7):e0132585. doi: 10.1371/journal.pone.0132585. eCollection 2015.

Supplemental Content

Support Center